FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is Australian healthcare stocks
Pantoro Gold’s operational setbacks and missed production targets overshadow a high-quality gold asset
Artificial intelligence is poised to change the world, but identifying who will ultimately create shareholder value out of this new technology remains a challenge, says Robert M. Almeida, Portfolio Manager and Global Investment Strategist MFS Investment Management
While SpaceX is reshaping the long-term telecommunications landscape, analysts believe Aussie Broadband’s near-term earnings outlook and valuation remain attractive
Middle East conflict accelerating the global energy transition, although it’s not that easy; Macquarie’s fossil fuel financing questioned; US slavery tariff exposes Australian weakness; winners & losers in human capital management
Supplier surveys and consumer spending data have analysts divided over supermarket valuations and where the best value lays across the consumer sector
Tony Sycamore, Market Analyst, IG shares his technical views on the Nasdaq, ASX200, gold and crude oil
While one broker has turned more cautious on ResMed due to a one-off cost and risk of rising competition, analysts broadly welcome the MatrixCare sale as a strategic refocus backed by a sizeable shareholder return
Rio Tinto shares appear to be stabilising after their recent decline. Fairmont Equities’ Michael Gable sees potential for a near-term recovery
Mike Fox, Head of Equities at Royal London Asset Management, argues labeling AI a ‘bubble’ is not doing investors any favours. Better to keep an open mind
